Celgenyx Gene Technology

China-based Hangzhou Celgenyx Gene Technology Co., Ltd has announced the completion of a Series A financing round, raising RMB 100 million (USD 13.68 million). The round was led by Vivo Capital. The proceeds will be directed toward the research and development of Celgenyx’s next-generation off-the-shelf cell therapy. Current Landscape of…